259 related articles for article (PubMed ID: 16567816)
1. Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.
Cohen D; Stolk RP; Grobbee DE; Gispen-de Wied CC
Diabetes Care; 2006 Apr; 29(4):786-91. PubMed ID: 16567816
[TBL] [Abstract][Full Text] [Related]
2. Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?
Sengupta S; Parrilla-Escobar MA; Klink R; Fathalli F; Ying Kin Ng ; Stip E; Baptista T; Malla A; Joober R
Schizophr Res; 2008 Jul; 102(1-3):329-36. PubMed ID: 18396386
[TBL] [Abstract][Full Text] [Related]
3. [Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].
Chen X; Su M; Wang C; Wu Z; Li S; Ying X; Wei G; Fu C; Jiang Q
Wei Sheng Yan Jiu; 2015 Nov; 44(6):881-6. PubMed ID: 26738376
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotics and glucose homeostasis.
Bergman RN; Ader M
J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
[TBL] [Abstract][Full Text] [Related]
5. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.
Utzschneider KM; Prigeon RL; Faulenbach MV; Tong J; Carr DB; Boyko EJ; Leonetti DL; McNeely MJ; Fujimoto WY; Kahn SE
Diabetes Care; 2009 Feb; 32(2):335-41. PubMed ID: 18957530
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
[TBL] [Abstract][Full Text] [Related]
7. Body composition, pre-diabetes and cardiovascular disease risk in early schizophrenia.
Strassnig M; Clarke J; Mann S; Remington G; Ganguli R
Early Interv Psychiatry; 2017 Jun; 11(3):229-236. PubMed ID: 25752319
[TBL] [Abstract][Full Text] [Related]
8. Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.
Sernyak MJ; Gulanski B; Leslie DL; Rosenheck R
J Clin Psychiatry; 2003 May; 64(5):605-8. PubMed ID: 12755666
[TBL] [Abstract][Full Text] [Related]
9. Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration.
Guina J; Roy S; Gupta A; Langleben DD; Elman I
Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28573760
[TBL] [Abstract][Full Text] [Related]
10. Beta-cell Function and Metabolic Clearance Rate of Glucose in Patients with Major Mental Health Disorders on Antipsychotic Drug Treatment.
Akinlade KS; Rahamon SK; Lasebikan VO
J Natl Med Assoc; 2018 Oct; 110(5):504-511. PubMed ID: 30129504
[TBL] [Abstract][Full Text] [Related]
11. Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy.
Wysokiński A
Diabetes Metab Syndr; 2014; 8(4):236-41. PubMed ID: 25311817
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients.
Arranz B; Rosel P; Ramírez N; Dueñas R; Fernández P; Sanchez JM; Navarro MA; San L
J Clin Psychiatry; 2004 Oct; 65(10):1335-42. PubMed ID: 15491236
[TBL] [Abstract][Full Text] [Related]
13. [Schizophrenia, diabetes mellitus and antipsychotics].
Gury C
Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
Jensen CC; Cnop M; Hull RL; Fujimoto WY; Kahn SE;
Diabetes; 2002 Jul; 51(7):2170-8. PubMed ID: 12086947
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia.
Newcomer JW; Haupt DW; Fucetola R; Melson AK; Schweiger JA; Cooper BP; Selke G
Arch Gen Psychiatry; 2002 Apr; 59(4):337-45. PubMed ID: 11926934
[TBL] [Abstract][Full Text] [Related]
19. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
[TBL] [Abstract][Full Text] [Related]
20. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.
Chen DC; Du XD; Yin GZ; Yang KB; Nie Y; Wang N; Li YL; Xiu MH; He SC; Yang FD; Cho RY; Kosten TR; Soares JC; Zhao JP; Zhang XY
Psychol Med; 2016 Nov; 46(15):3219-3230. PubMed ID: 27604840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
